These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 26846099
1. Prognostic significance of nuclear or cytoplasmic nucleolin expression in human non-small cell lung cancer and its relationship with DNA-PKcs. Xu JY, Lu S, Xu XY, Hu SL, Li B, Li WX, Chang JY. Tumour Biol; 2016 Aug; 37(8):10349-56. PubMed ID: 26846099 [Abstract] [Full Text] [Related]
5. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer. Wang WP, Yan XL, Li WM, Ni YF, Zhao JB, Lu Q, Wang XJ, Sun Y, Chen P, Yan BY, Cui Y, Zhang ZP, Li XF. Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593 [Abstract] [Full Text] [Related]
6. Prognostic significance of MCM7 expression in the bronchial brushings of patients with non-small cell lung cancer (NSCLC). Liu YZ, Jiang YY, Hao JJ, Lu SS, Zhang TT, Shang L, Cao J, Song X, Wang BS, Cai Y, Zhan QM, Wang MR. Lung Cancer; 2012 Jul; 77(1):176-82. PubMed ID: 22456526 [Abstract] [Full Text] [Related]
7. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer. Zhang D, Jin X, Wang F, Wang S, Deng C, Gao Z, Guo C. Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287 [Abstract] [Full Text] [Related]
14. Tyrosine-protein phosphatase non-receptor type 12 expression is a good prognostic factor in resectable non-small cell lung cancer. Cao X, Chen YZ, Luo RZ, Zhang L, Zhang SL, Zeng J, Jiang YC, Han YJ, Wen ZS. Oncotarget; 2015 May 10; 6(13):11704-13. PubMed ID: 25868976 [Abstract] [Full Text] [Related]
15. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer. Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS. Oncol Rep; 2006 Dec 10; 16(6):1205-10. PubMed ID: 17089038 [Abstract] [Full Text] [Related]
16. Prognostic significance of TAZ expression in resected non-small cell lung cancer. Xie M, Zhang L, He CS, Hou JH, Lin SX, Hu ZH, Xu F, Zhao HY. J Thorac Oncol; 2012 May 10; 7(5):799-807. PubMed ID: 22481233 [Abstract] [Full Text] [Related]
17. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Xing J, Wu X, Vaporciyan AA, Spitz MR, Gu J. Cancer; 2008 Jun 15; 112(12):2756-64. PubMed ID: 18457328 [Abstract] [Full Text] [Related]
18. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer. Liu K, Chen HL, Gu MM, You QS. Int J Biol Markers; 2015 Feb 24; 30(1):e43-8. PubMed ID: 25450647 [Abstract] [Full Text] [Related]
19. Association of cytoplasmic p27 expression with an unfavorable response to cisplatin-based chemotherapy and poor outcomes in non-small cell lung cancer. Lin TC, Tsai LH, Chou MC, Chen CY, Lee H. Tumour Biol; 2016 Mar 24; 37(3):4017-23. PubMed ID: 26482622 [Abstract] [Full Text] [Related]
20. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC. Luo YQ, Ming Z, Zhao L, Yao LJ, Dong H, Du JP, Wu SZ, Hu W. IUBMB Life; 2012 May 24; 64(5):423-31. PubMed ID: 22473740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]